Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS approval · 2025-12-15

Clinical Trial Update: Treatment on HBeAg Positive or HBeAg Negative in Chronic Hepatitis B

View source ↗

Summary

The update notes that a treatment for chronic hepatitis B, including patients regardless of HBeAg status, has been approved for marketing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Nguyen Thi Trieu, MD | Conditions: CHRONIC HEPATITIS B | Status: APPROVED_FOR_MARKETING